Grave’s Disease and Risk of Systemic Lupus Erythematosus

Grave's disease and risk of incident SLE: A nationwide population-based cohort study BACKGROUND Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease that causes damage to multiple tissues and organs, including the thyroid gland. Several authors have linked Grave’s disease, an autoimmune disease characterized by an overactive thyroid gland, to incident

Benign Thyroid Nodule Removal and Patient Satisfaction

Benign Thyroid Nodule Removal and Patient Satisfaction The thyroid plays an important role in producing hormones that the blood carries to every tissue in the body. The thyroid helps regulate metabolism, the process by which the body turns food into energy, and keeps the organs functioning properly by helping the body

Esophageal Cancer: Pembrolizumab VS Chemotherapy treatment?

Esophageal Cancer: Pembrolizumab VS Chemotherapy treatment? Esophageal cancer is cancer that occurs in the esophagus. The esophagus plays an important role in digesting food it helps in moving the food you swallow down to your stomach. Esophageal cancer is the seventh most common cancer and the sixth most common cause of cancer-related

Metastatic Renal Cell Carcinoma: A Meta‑Analysis Review of Therapy

Metastatic Renal Cell Carcinoma: A Meta‑Analysis Review of Therapy Background In 2021, there will be an estimated 76,080 new cases of kidney cancer in the US (48,780 in men and 27,300 in women) and about 13,780 patients (4,990 women, 8,790 men) will die from this disease. The most common form of kidney

Optic 3D Modeling in Ophthalmic Treatment

Optic 3D Modeling in Ophthalmic Treatment Visual impairment is a global health concern. Visually impaired patients are at high risk for accidents, depression, and social withdrawal. Eye disorders like age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, and retinitis pigmentosa (RP) cause irreparable vision loss and affect the quality of life of

iStent Combination Therapy for Glaucoma and Cataracts

iStent Combination Therapy for Glaucoma and Cataracts Considering that glaucoma is the most common cause of irreversible vision loss and the third most common cause of vision loss worldwide, with cataracts and refractive error being the most prevalent causes, iStent combination therapy to treat glaucoma and cataracts has high therapeutic value. 

Thermography in clinical ophthalmic oncology

THERMOGRAPHY AS A SCREENING TOOL IN CLINICAL OPHTHALMIC ONCOLOGY STUDY BACKGROUND Although intraocular tumors are rare, with an incidence of 5 per million adults, the diagnosis has been biased towards the physical examination, Color Doppler Imaging (CDI), Optical Coherence Tomography (OCT), Indocyanine Green Angiography (ICGA), or Fluorescein Angiography (FA). Literature reviews suggest

Combination IOP Reduction Therapy in Open-Angle Glaucoma

Combination IOP Reduction Therapy in Open-Angle Glaucoma GLAUCOMA BACKGROUND Globally, glaucoma is a leading cause of permanent blindness. As of 2020, about 80 million people worldwide, and 3 million Americans, are affected by glaucoma. The most common form of glaucoma is open-angle glaucoma. Unfortunately, the primary risk factor for open-angle glaucoma is

Stroke in the Presence of Kidney Disease

Stroke in the Presence of Kidney Disease Stroke is a life-threatening medical condition that occurs when blood supply to the part of the brain is cut off. It is one of the leading causes of death and disability around the world. Most strokes are caused by blockage of arteries to the